Cargando…
Safety and efficacy of sorafenib in patients with advanced thyroid carcinoma: a phase II study (NCT02084732)
OBJECTIVE: Sorafenib significantly prolonged progression-free survival in patients with iodine-refractory advanced thyroid cancer. The present study was initiated before sorafenib was approved in Colombia and therefore represents an effort by an oncology institution to evaluate its efficacy and safe...
Autores principales: | Fierro-Maya, Luis Felipe, González, Gloria Garavito, Rojas Melo, Leonardo Javier, Cuéllar Cuéllar, Andrés Arturo, Carreño, Alexander, Córdoba, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Endocrinologia e Metabologia
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522190/ http://dx.doi.org/10.20945/2359-3997000000373 |
Ejemplares similares
-
Metastatic differentiated thyroid cancer: worst prognosis in patients with metachronous metastases
por: González-Clavijo, Angélica María, et al.
Publicado: (2023) -
BALB.NCT-Cpox(nct) is a unique mouse model of hereditary coproporphyria
por: Kang, Xiaojing, et al.
Publicado: (2023) -
Safety and tolerability of sorafenib in patients with radioiodine-refractory thyroid cancer
por: Worden, Francis, et al.
Publicado: (2015) -
"Revisión bibliográfica del herpes zóster y su incidencia en la unidad médico familiar no. 32 del I.M.S.S., en el año de 1991" /
por: Rodríguez Cuellar Arturo
Publicado: (1992) -
Potential role of sorafenib as neoadjuvant therapy in unresectable papillary thyroid cancer
por: Danilovic, Debora L. S., et al.
Publicado: (2018)